Cancer 16 , 330339 (2016)
The peptide needs to arrive at pituitary GHRH receptors intact and in sufficient concentration to produce a measurable GH pulse
Takahashi K, Kamada C, Yoshimura H, Okumura R, Iimuro S, Ohashi Y,
Clinical observations report that subcutaneous dosing 3060 minutes before bedtime shortens sleep latency and increases deepsleep proportion within 12 weeks, with optimal benefits after 68 weeks of therapy Peptide therapy improves sleep by restoring natural hormone production

Major Ingredients Water, Glycerin, Dipropylene Glycol, Niacinamide, Methylpropanediol, 1,2-Hexanediol, Panthenol, Hydroxyacetophenone, Ethylhexyl Palmitate, Gluconolactone, Polyglyceryl-10 Laurate, Pentylene Glycol, Butylene Glycol, Arginine, Cetyl Ethylhexanoat, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Ethylhexylglycerin, Methyl Diisopropyl Propionamide, Adenosine, Polyglyceryl-4 Laurate, Xanthan Gum, Disodium EDTA, Sodium Hyaluronate, Allantoin, Fragrance, Hydrogenated Lecithin, Tranexamic Acid, Glutathione(10ppm), Candida Bombicola/Glucose/Methyl Rapeseedate Ferment, Pueraria Lobata Root Extract, Pinus Palustris Leaf Extract, Ulmus Davidiana Root Extract, Oenothera Biennis (Evening Primrose) Flower Extract, Ascorbic acid, Helianthus Annuus (Sunflower) Seed Oil Ingredients subject to change at manufacturer's discretion
They work with TPOCs to ensure that the technology is maturing fast enough to meet agency needs